Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Cp 70429
2. Cp-70,429
3. Cp-70429
1. Cp-70429
2. Cp-70,429
3. 120788-07-0
4. Xx514bj1xw
5. (5r,6s)-6-((1r)-1-hydroxyethyl)-7-oxo-3-(((3s)-tetrahydro-3-thienyl)thio)-4-thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic Acid, (r)-s-oxide
6. Sulopenem [inn]
7. Sulopenem (usan/inn)
8. Sulopenem [usan]
9. Schembl2256409
10. Chembl1908305
11. Sulopenem, >=98% (hplc)
12. Gtpl10862
13. Dtxsid20869656
14. Ex-a4518
15. Zinc3781858
16. Cp-65207-s
17. Cp70429
18. Db15284
19. Ac-33244
20. Hy-105284
21. Cs-0025618
22. D05969
23. Q27294038
24. (5r,6s)-6-((1r)-1-hydroxyethyl)-7-oxo-3-(((1r,3s)-1-oxotetrahydro-1h-1.lamba.(sup 4)-thiophen-3-yl)sulfanyl)-4-thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic Acid
25. (5r,6s)-6-[(1r)-1-hydroxyethyl]-7-oxo-3-[(1r,3s)-1-oxothiolan-3-yl]sulfanyl-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid
26. 4-thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic Acid, 6-((1r)-1-hydroxyethyl)-7-oxo-3-(((1r,3s)-tetrahydro-1-oxido-3-thienyl)thio)-, (5r,6s)-
27. 4-thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic Acid, 6-(1-hydroxyethyl)-7-oxo-3-((tetrahydro-3-thienyl)thio)-, S-oxide, (5r-(3(1r*,3s*),5.alpha.,6.alpha.(r*)))-
| Molecular Weight | 349.5 g/mol |
|---|---|
| Molecular Formula | C12H15NO5S3 |
| XLogP3 | 0 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 4 |
| Exact Mass | 349.01123610 g/mol |
| Monoisotopic Mass | 349.01123610 g/mol |
| Topological Polar Surface Area | 165 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 563 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
64
PharmaCompass offers a list of Sulopenem API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sulopenem manufacturer or Sulopenem supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sulopenem manufacturer or Sulopenem supplier.
PharmaCompass also assists you with knowing the Sulopenem API Price utilized in the formulation of products. Sulopenem API Price is not always fixed or binding as the Sulopenem Price is obtained through a variety of data sources. The Sulopenem Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sulopenem manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sulopenem, including repackagers and relabelers. The FDA regulates Sulopenem manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sulopenem API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sulopenem supplier is an individual or a company that provides Sulopenem active pharmaceutical ingredient (API) or Sulopenem finished formulations upon request. The Sulopenem suppliers may include Sulopenem API manufacturers, exporters, distributors and traders.
Sulopenem Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sulopenem GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sulopenem GMP manufacturer or Sulopenem GMP API supplier for your needs.
A Sulopenem CoA (Certificate of Analysis) is a formal document that attests to Sulopenem's compliance with Sulopenem specifications and serves as a tool for batch-level quality control.
Sulopenem CoA mostly includes findings from lab analyses of a specific batch. For each Sulopenem CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sulopenem may be tested according to a variety of international standards, such as European Pharmacopoeia (Sulopenem EP), Sulopenem JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sulopenem USP).
